IMGT® databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr

Leukemia

Volumn 17, Issue 1, 2003, Pages 260-266

  Lefranc, M P ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Database; Immunoglobulin; Leukemia; Lymphoma; Rearrangement; T cell receptor

Indexed keywords

IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR; OLIGONUCLEOTIDE; T LYMPHOCYTE RECEPTOR;

ACCESS TO INFORMATION; AMINO ACID SEQUENCE; ARTICLE; FRANCE; GENE MAPPING; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC DATABASE; GENETIC POLYMORPHISM; HUMAN; IMMUNOGENETICS DATABASE; INFORMATION SYSTEM; INTERNET; LEUKEMIA; LYMPHOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUALITY CONTROL; SEQUENCE ANALYSIS; STANDARDIZATION; T LYMPHOCYTE; THREE DIMENSIONAL IMAGING; UNIVERSITY; CHEMISTRY; FACTUAL DATABASE; GENETICS; IMMUNOGENETICS; MOLECULAR GENETICS; REVIEW; SEQUENCE ALIGNMENT; SYSTEM ANALYSIS;

AMINO ACID SEQUENCE; BASE SEQUENCE; DATABASES, FACTUAL; HUMANS; IMMUNOGENETICS; IMMUNOGLOBULINS; INTERNET; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL; SEQUENCE ALIGNMENT; SYSTEMS INTEGRATION;

EID: 0037208270     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402637     Document Type: Article

References (51)

1. Lefranc M-P, Lefranc G. The Immunoglobulin FactsBook. Academic Press: London, 2001.
2. Lefranc M-P, Lefranc G. The T Cell Receptor FactsBook. Academic Press: London, 2001.
3. Stoesser G, Baker W, Van den Broek A, Camon E, Garcia-Pastor M, Kanz C, Kulikova T, Lombard V, Lopez R, Parkinson H, Redaschi N, Sterk P, Stoehr P, Tuli M-A. The EMBL nucleotide sequence database. Nucleic Acids Res 2001; 29: 17-21.
4. Benson DA, Karsch-Mizrachi I, Lipman D, Ostell J, Rapp BA, Wheeler DL. GenBank. Nucleic Acids Res 2000; 28: 15-18.
5. Tateno Y, Miyazaki S, Ota M, Sugawara H, Gojobori T. DNA Data Bank of Japan (DDBJ) in collaboration with mass sequencing teams. Nucleic Acids Res 2000; 28: 24-26.
6. Lefranc M-P. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 2001; 29: 207-209.
7. Giudicelli V, Chaume D, Bodmer J, Müller W, Busin C, Marsh S, Bontrop R, Lemaitre M, Malik, Lefranc M-P. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 1997; 25: 206-211.
8. Lefranc M-P, Giudicelli V, Busin C, Bodmer J, Müller W, Bontrop R, Lemaitre M, Malik A, Chaume D. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 1998; 26: 297-303.
9. Lefranc M-P, Giudicelli V, Ginestoux C, Bodmer J, Müller W, Bontrop R, Lemaitre M, Malik A, Barbié V, Chaume D. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 1999; 27: 209-212.
10. Ruiz M, Giudicelli V, Ginestoux C, Stoehr P, Robinson J, Bodmer J, Marsh SG, Bontrop R, Lemaitre M, Lefranc G, Chaume D, Lefranc M-P. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 2000; 28: 219-221.
11. Ruiz M, Lefranc M-P. IMGT gene identification and Colliers de Perles of human immunoglobulin with known 3D structures. Immunogenetics DOI 10.1007/s00251-001-0408-6. Immunogenetics 2002; 53: 857-883.
12. Robinson J, Malik A, Parham P, Bodmer JG, Marsh SGE. IMGT/HLA Database - a sequence database for the human major histocompatibility complex. Tissue Antigens 2000; 55: 280-287.
13. Giudicelli V, Lefranc M-P. Ontology for Immunogenetics: IMGT-ONTOLOGY. Bioinformatics 1999; 12: 1047-1054.
14. Lefranc M-P. Nomenclature of the human immunoglobulin genes. Current Protocols in Immunology. J Wiley and Sons: New York, 2000, Suppl. 40, A.1 P.1-A.1 P.37.
15. Lefranc M-P. Nomenclature of the human T cell Receptor genes. Current Protocols in Immunology. J Wiley and Sons: New York, USA, 2000, Suppl. 40, A.1O.1-A.1O.23.
16. Lefranc M-P. Locus maps and genomic repertoire of the human Ig genes. Immunologist 2000; 8: 80-87.
17. Lefranc M-P. Locus maps and genomic repertoire of the human T-cell receptor genes. Immunologist 2000; 8: 72-79.
18. Lefranc M-P. Nomenclature of the human immunoglobulin heavy (IGH) genes. Exp Clin Immunogenet 2001; 18: 100-116.
19. Lefranc M-P. Nomenclature of the human immunoglobulin kappa (IGK) genes. Exp Clin Immunogenet 2001; 18: 161-174.
20. Lefranc M-P. Nomenclature of the human immunoglobulin lambda (IGL) genes. Exp Clin Immunogenet 2001; 18: 242-254.
21. Lefranc M-P. IMGT (ImMunoGeneTics) Locus on Focus. A new section of experimental and clinical immunogenetics. Exp Clin Immunogenet 1998; 15: 1-7.
22. Pallarès N, Frippiat JP, Giudicelli V, Lefranc M-P. The human immunoglobulin lambda variable (IGLV) genes and joining (IGLJ) segments. Exp Clin Immunogenet 1998; 15: 8-18.
23. Barbié V, Lefranc M-P. The human immunoglobulin kappa variable (IGKV) genes and joining (IGKJ) segments. Exp Clin Immunogenet 1998; 15: 171-183.
24. Pallarès N, Lefebvre S, Contet V, Matsuda F, Lefranc M-P. The human immunoglobulin heavy variable (IGHV) genes. Exp Clin Immunogenet 1999; 16: 36-60.
25. Ruiz M, Pallarès N, Contet V, Barbié V, Lefranc M-P. The human immunoglobulin heavy diversity (IGHD) and joining (IGHJ) segments. Exp Clin Immunogenet 1999; 16:173-184.
26. Folch G, Lefranc M-P. The human T cell receptor beta variable (TRBV) genes. Exp Clin Immunogenet 2000; 17: 42-54.
27. Scaviner D, Lefranc M-P. The human T cell receptor alpha variable (TRBV) genes. Exp Clin Immunogenet 2000; 17: 83-96.
28. Scaviner D, Lefranc M-P. The human T cell receptor alpha joining (TRAJ) genes. Exp Clin Immunogenet 2000; 17: 97-106.
29. Folch G, Lefranc M-P. The human T cell receptor beta diversity (TRBD) and beta joining (TRBJ) genes. Exp Clin Immunogenet 2000; 17: 107-114.
30. Scaviner D, Barbié V, Ruiz M, Lefranc M-P. Protein displays of the human immunoglobulin heavy, kappa and lambda variable and joining regions. Exp Clin Immunogenet 1999; 16: 234-240.
31. Folch G, Scaviner D, Contet V, Lefranc M-P. Protein displays of the human T cell receptor alpha, beta, gamma and delta variable and joining regions. Exp Clin Immunogenet 2000; 17: 205-215.
32. Lefranc M-P. Unique database numbering system for immunogenetic analysis. Immunol Today 1997; 18: 509.
33. Lefranc M-P. The IMGT unique numbering for Immunoglobulins, T cell receptors and Ig-like domains. Immunologist 1999; 7: 132-136.
34. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of Proteins of Immunological Interest. National Institute of Health Publications: Washington DC, 1991, 91-3242.
35. Satow Y, Cohen GH, Padlan EA, Davies DR. Phosphocholine binding immunoglobulin Fab McPC603. J Mol Biol 1986; 190: 593-604.
36. Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987; 196: 901-917.
37. Lefranc M-P. Web sites of Interest to immunologists. Current Protocols in Immunology. J Wiley and Sons: New York, 2000, A.1J.1-A.1J.33.
38. Giudicelli V, Chaume D, Lefranc M-P. IMGT/LIGM-DB: A systematized approach for ImMunoGeneTics database coherence and data distribution improvement. Proceedings of the Sixth International Conference on Intelligent Systems for Molecular Biology, ISBM-98, 1998, 59-68.
39. Giudicelli V, Chaume D, Mennessier G, Althaus HH, Mller W, Bodmer J, Malik A, Lefranc M-P. IMGT, the international ImMunoGeneTics database: a new Design for Immunogenetics Data Access. In: Cesnik B et al (eds). Proceedings of the Ninth World Congress on Medical Informatics, MEDINFO' 98. IOS Press: Amsterdam, 1998, pp 351-355.
40. Lefranc M-P. IMGT, the international ImMunoGeneTics database: a high-quality information system for comparative immmunogenetics and immunology. Dev Comp Immunol (in press).
41. Eckert C, Landt O, Taube T, Seeger K, Beyermann B, Proba J, Henze G. Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 316-323.
42. Delabesse E, Burtin ML, Millien C, Madonik A, Arnulf B, Beldjord K, Valensi F, Macintyre EA. Rapid, multifluorescent TCRG Vgamma and Jgamma typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations. Leukemia 2000; 14: 1143-1152.
43. Szczepanski T, Langerak AW, Willemse MJ, Wolvers-Tettero ILM, van Wering ER, van Dongen JJM. T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect 'end-stage' recombinations: implications for minimal residual disease monitoring. Leukemia 2000; 14: 1208-1214.
44. Bruggemann M, Droese J, Bolz I, Luth P, Pott C, von Neuhoff N, Scheuering U, Kneba M. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR. Leukemia 2000; 14: 1419-1425.
45. Verhagen OJHM, Willemse MJ, Breunis WB, Wijkhuijs AJM, Jacobs DCH, Joosten SA, van Wering ER, van Dongen JJM, van der Schoot CE. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000; 14: 1426-1435.
46. De Haas V, Verhagen OJ, von dem Borne AE, Kroes W, van den Berg H, van der Schoot CE. Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy. Leukemia 2001; 15: 134-140.
47. Szczepanski T, Willemse MJ, van Wering ER, Weerden JF, Kamps WA, van Dongen JJM. Precursor-B-ALL with DH-JH gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia 2001; 15: 1415-1423.
48. Moreira I, Papaioannou M, Mortuza FY, Gameiro P, Palmisano GL, Harrison CJ, Prentice HG, Mehta AB, Hoffbrand AV, Foroni L. Heterogeneity of VH-JH gene rearrangement patterns: an insight into the biology of B cell precursor ALL. Leukemia 2001; 15: 1527-1536.
49. Boeckx N, Willemse MJ, Szczepanski T, van Der Velden VHJ, Langerak AW, Vandekerckhove P, van Dongen JJM. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia. Leukemia 2002; 16: 368-375.
50. Van der Velden VHJ, Wijkhuijs JM, Jacobs DCH, van Wering ER, van Dongen JJM. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia 2002; 16: (in press).
51. Van der Velden VHJ, Willemse MJ, van der Schoot CE, van Wering ER, van Dongen JJM. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia 2002; 16: (in press).